| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/23/2003 | WO2002061424A3 Organ system microarrays |
| 01/23/2003 | WO2002058026A9 System for warning device having information interface |
| 01/23/2003 | WO2002057763A3 Apparatus and method for identification of crystals by in-situ x-ray diffraction |
| 01/23/2003 | WO2002057739A3 Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples |
| 01/23/2003 | WO2002054074A3 Recognition of tumor-specific gene products in cancer |
| 01/23/2003 | WO2002050302A3 Protein-protein interactions |
| 01/23/2003 | WO2002048388A9 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 01/23/2003 | WO2002047466A3 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
| 01/23/2003 | WO2002045570A3 Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
| 01/23/2003 | WO2002044702A3 Adsorption based carbon monoxide sensor and method |
| 01/23/2003 | WO2002038724A3 A method for the detection of viable microorganisms |
| 01/23/2003 | WO2002036741A3 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 01/23/2003 | WO2002033095A3 Regulation of human serine-threonine protein kinase |
| 01/23/2003 | WO2002029059A3 Nogo receptor homologs |
| 01/23/2003 | WO2002025287A3 Detection of peptides |
| 01/23/2003 | WO2002024325A3 Acoustic ejection of fluids from a plurality of reservoirs |
| 01/23/2003 | WO2002022794A3 ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE |
| 01/23/2003 | WO2002021128A3 Cellular arrays comprising encoded cells |
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | WO2002016939A3 Methods of diagnosis of cancer and screening for cancer modulators |
| 01/23/2003 | WO2002016598A3 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 01/23/2003 | WO2002016553A3 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002008858A3 A method for ab initio determination of macromolecular crystallographic phases using bessel function |
| 01/23/2003 | WO2002008415A1 METHOD OF SCREENING PTPz ACTIVITY PROMOTER OR INHIBITOR |
| 01/23/2003 | WO2002008262A3 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/23/2003 | WO2002006513A3 A method for treating herpes viruses |
| 01/23/2003 | WO2002004946A3 Methods for identifying combinations of drugs |
| 01/23/2003 | WO2002004113A3 Methods of patterning protein and cell adhesivity |
| 01/23/2003 | WO2001097843A3 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 01/23/2003 | WO2001084161A3 Process for the measurement of non-transferrin bound iron |
| 01/23/2003 | WO2001084160A3 Proteomic determination of protein nitrotyrosine modifications using mass spectrometry |
| 01/23/2003 | WO2001083824A3 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 01/23/2003 | WO2001066568A3 Use of recombinant antigens to determine the immune status of an animal |
| 01/23/2003 | WO2001063280A3 Inter-alpha-trypsin as a marker for sepsis |
| 01/23/2003 | WO2001063279A3 Method of identifying toxic agents using differential gene expression |
| 01/23/2003 | WO2001061048A3 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 01/23/2003 | WO2001053520A3 Gene chip for neonate screening |
| 01/23/2003 | WO2001007647A9 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 01/23/2003 | US20030018987 Animal model for use in the diagnosis and treatment of eating, apoptosis and infectious disorders |
| 01/23/2003 | US20030018616 Systems, methods and computer program products for integrating databases to create an ontology network |
| 01/23/2003 | US20030018438 Binding compounds and methods for identifying binding compounds |
| 01/23/2003 | US20030018182 A cDNA encoding a non-endogenous, constitutively activated version of a human G protein-coupled receptor |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018178 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030018177 Method for nucleic acid isolation and kit |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018113 Method of testing rubber composition for kneaded state and process for producing rubber composition |
| 01/23/2003 | US20030018078 Glaucoma treatments with reduced hyperpigmentation |
| 01/23/2003 | US20030018051 Pyrazole derivatives - p38 MAP kinase inhibitors |
| 01/23/2003 | US20030018047 Central nervous system disorders; psychological disorders |
| 01/23/2003 | US20030017995 Dialysis solutions and methods |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017984 Binding to ligand; crystallization; cardiovascular disorders; Alzheimer's disease |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017966 MC4-R as target for the identification of compounds used to treat drug addiction |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | US20030017619 Test method for IgA nephropathy |
| 01/23/2003 | US20030017618 Apparatus for use in the detection of preferential particles in sample |
| 01/23/2003 | US20030017616 Solid phase for use in the detection of preferential particles in sample |
| 01/23/2003 | US20030017615 Immunoassay for use in the sensitive detection of a preferential particle in biological fluid sample |
| 01/23/2003 | US20030017614 Apparatus for use in monitoring toxicity of sample |
| 01/23/2003 | US20030017606 Method for confirming presence of mycotoxicosis |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017581 Reproduction of preferential pattern on surface; obtain substrate, apply to pattern support, apply liquid to support, roll, hardening, cure, detach pattern substrate from support, duplicate procedure |
| 01/23/2003 | US20030017580 Generation of solid support for colorimetric analysis; obtain liquid capable of being transformed into flexible solid, deposit on surface ofsolid structure, transform to flexible solid, peel off solid structure, cure, apply film, recover |
| 01/23/2003 | US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017536 Novel polypeptide |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017533 Slo2 and Slo4, novel potassium channel proteins from human brain |
| 01/23/2003 | US20030017532 ndp |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017525 Apparatus for use in monitoring cell activities |
| 01/23/2003 | US20030017523 Method of measuring lipid components and method of examining of renal failure |
| 01/23/2003 | US20030017521 Treatment and prevention of bacterial infections; obtain human, administer microbicide, monitor presence of preferential microorganism |
| 01/23/2003 | US20030017520 High-efficiency assay for protein mannosyl transferases |
| 01/23/2003 | US20030017519 Electrochemical enzyme assay |
| 01/23/2003 | US20030017518 Detecting modulators of lipopolysaccharide phosphorylation; obtain test sample, incubate with antibody, monitor phosphorylation lipopolysaccharides |
| 01/23/2003 | US20030017515 Detection of ovarian cancer in humans; obtain fluid sample, determine concentration of haptoglobin, compare to control, evaluate for ovarian cancer |
| 01/23/2003 | US20030017514 Quantitative analysis of tumor cells; obtain body fluids, label epithelial tumor cells, immobilize on solid support, laser scan, evaluate and count cells |
| 01/23/2003 | US20030017513 Disgnostic tool for use in the detection of cancer |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017511 Nuclear myosin l beta with a 16 amino acid N-terminal extension |
| 01/23/2003 | US20030017510 Apparatus for use in cell transplantation |
| 01/23/2003 | US20030017509 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 01/23/2003 | US20030017508 Solid support of protein-binding agents for use protein analysis |
| 01/23/2003 | US20030017507 Labeling preferential biopolymers; obtain bipolymer sample, incubate with label, insert label into protein, recover protein |
| 01/23/2003 | US20030017506 Marker for the detection of free radical damage in cells |
| 01/23/2003 | US20030017505 Methods for determining risk of developing cervical cancer |
| 01/23/2003 | US20030017503 Methods and labeled molecules for determining ligand binding to steroid receptors |
| 01/23/2003 | US20030017502 Methods involving the use of capG as a diagnostic marker and methods for the identification of capG modulators for the treatment and prevention of osteoporosis and related disease states |
| 01/23/2003 | US20030017501 Diagnostics and therapeutics for macular degeneration-related disorders |
| 01/23/2003 | US20030017500 Secreted protein HT5GJ57 |